Publications by authors named "Agnes Pocskay"
Article Synopsis
- The study monitored drug resistance mutations in newly diagnosed, treatment-naive HIV-positive patients in Hungary from 2017 to 2019, focusing on integrase inhibitors alongside other treatment types.
- One major integrase mutation was found in 1 out of 249 samples, with accessory mutations in 12.4% of patients, showing some level of resistance.
- The overall prevalence of transmitted drug resistance (TDR) for other inhibitors was 5.8%, highlighting the need for ongoing surveillance to inform treatment strategies in Hungary.
Objectives: Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance (TDR) may affect the success of first-line antiretroviral treatment. This study aimed to monitor the presence of HIV-1 strains carrying transmitted drug resistance-associated mutations (TDRMs) in newly diagnosed and treatment-naïve patients in Hungary.
Methods: This study included 168 HIV-infected individuals diagnosed between 2013-2017; most of them (93.